BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/28/2020 10:48:48 AM | Browse: 661 | Download: 851
 |
Received |
|
2020-06-01 14:37 |
|
Peer-Review Started |
|
2020-05-31 21:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-10-04 03:23 |
|
Revised |
|
2020-10-14 02:51 |
|
Second Decision |
|
2020-10-26 00:11 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-10-26 04:01 |
|
Articles in Press |
|
2020-10-26 04:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-10-28 00:34 |
|
Publish the Manuscript Online |
|
2020-10-28 10:48 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maliha Naseer, Shiva Poola, Francis E Dailey, Hakan Akin and Veysel Tahan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Veysel Tahan, FACG, FACP, FEBG, MD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, 1 Hospital Drive, Columbia, MO 65212, United States. tahanv@health.missouri.edu |
| Key Words |
SARS-CoV-2; COVID-19; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Pandemic |
| Core Tip |
The current pandemic caused by coronavirus disease 2019 (COVID-19) has resulted in devastating consequences worldwide. This viral infection affecting the respiratory and gastrointestinal systems is most severe in patients with co-morbid conditions, including the immunocompromised. Patients with inflammatory bowel disease are often malnourished and on immunosuppressive medications; management of this population poses unique challenges during this time. In this review, we summarize the current evidence and understanding of the management of inflammatory bowel disease during the COVID-19 pandemic. We further outline the current guidelines for treatment of those with inflammatory bowel disease and offer education for measures to prevent infections, including COVID-19. |
| Publish Date |
2020-10-28 10:48 |
| Citation |
Naseer M, Poola S, Dailey FE, Akin H, Tahan V. Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic. World J Meta-Anal 2020; 8(5): 383-399 |
| URL |
https://www.wjgnet.com/2308-3840/full/v8/i5/383.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v8.i5.383 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
